FORM DEF 14A

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

November 4, 2025

Period of Report

December 18, 2025

Accession Number

0001437749-25-033023

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →